Mycophenolate Mofetil Tablet

Mycophenolate Mofetil Tablet

Categories : Immunology

Product Packaging : 10 / 30 tablets

Product Composition : 500 mg

Mycophenolate Mofetil Tablets are a selective immunosuppressant therapy designed to control immune system activity in patients undergoing organ transplantation and those suffering from immune-mediated disorders. The formulation works by blocking purine synthesis in lymphocytes, thereby preventing immune cell proliferation and reducing the risk of graft rejection and tissue damage.

Genliva Wellness LLP stands as a reliable Mycophenolate Mofetil Tablets supplier in India, offering precision-formulated, GMP-certified pharmaceutical products. With expertise in third-party manufacturing, contract production, and global pharmaceutical exports, the company supports international partners with high-quality, regulatory-compliant immunosuppressant medicines.

Send Message

Mycophenolate Mofetil Tablets are a selective immunosuppressant therapy designed to control immune system activity in patients undergoing organ transplantation and those suffering from immune-mediated disorders. The formulation works by blocking purine synthesis in lymphocytes, thereby preventing immune cell proliferation and reducing the risk of graft rejection and tissue damage.

Genliva Wellness LLP stands as a reliable Mycophenolate Mofetil Tablets supplier in India, offering precision-formulated, GMP-certified pharmaceutical products. With expertise in third-party manufacturing, contract production, and global pharmaceutical exports, the company supports international partners with high-quality, regulatory-compliant immunosuppressant medicines.

  • Manufactured under strict GMP & ISO quality-controlled environments
  • Advanced immunosuppressive formulation for transplant care
  • Helps in reducing immune rejection risk effectively
  • Maintains uniform drug release and high bioavailability
  • Available for bulk export, private labeling, and institutional supply
  • Supported with complete documentation (COA, stability data, dossiers)
  • Designed for long-term clinical use in transplant protocols
  • Suitable for global pharmaceutical distribution networks
  • Prevention of organ rejection post kidney, liver, or heart transplantation
  • Treatment support in autoimmune conditions like lupus nephritis
  • Used in combination immunosuppressive regimens
  • Helps manage chronic immune-mediated inflammatory disorders
  • Supports long-term transplant survival and graft stability
  • Tablet dosage form ensures accurate dosing and patient convenience
  • Suitable for chronic therapy and outpatient treatment
  • Enables easy packaging, storage, and transportation
  • Provides cost-effective solution for bulk procurement
  • Ideal for private-label and contract manufacturing programs

whatsapp-app